These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 30173421)

  • 21. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    Krishna S; Lim CS; McInnes MDF; Flood TA; Shabana WM; Lim RS; Schieda N
    J Magn Reson Imaging; 2018 Jan; 47(1):176-185. PubMed ID: 28387981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Discussion of correlation between histogram analysis of quantitative diffusion weighted imaging and Gleason score of prostate cancer].
    Wen R; Zhao WL; Wei CG; Gu YF; Li MJ; Zhang YY; Shen JK
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):823-828. PubMed ID: 30893724
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology.
    Shan Y; Chen X; Liu K; Zeng M; Zhou J
    Abdom Radiol (NY); 2019 Oct; 44(10):3441-3452. PubMed ID: 31144091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics.
    Gong L; Xu M; Fang M; Zou J; Yang S; Yu X; Xu D; Zhou L; Li H; He B; Wang Y; Fang X; Dong D; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1102-1109. PubMed ID: 32212356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
    Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
    J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
    Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
    AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
    Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
    Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
    Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
    Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
    Sadoughi N; Krishna S; McInnes MDF; Flood TA; Breau RH; Morash C; Schieda N
    AJR Am J Roentgenol; 2018 Sep; 211(3):W158-W165. PubMed ID: 29995495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
    Han C; Ma S; Liu X; Liu Y; Li C; Zhang Y; Zhang X; Wang X
    J Magn Reson Imaging; 2021 Dec; 54(6):1892-1901. PubMed ID: 33682286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
    Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
    Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
    Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O
    Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.
    Pepe P; D'Urso D; Garufi A; Priolo G; Pennisi M; Russo G; Sabini MG; Valastro LM; Galia A; Fraggetta F
    In Vivo; 2017; 31(3):415-418. PubMed ID: 28438871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study.
    Peng Y; Jiang Y; Yang C; Brown JB; Antic T; Sethi I; Schmid-Tannwald C; Giger ML; Eggener SE; Oto A
    Radiology; 2013 Jun; 267(3):787-96. PubMed ID: 23392430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stretched-exponential and mono-exponential diffusion-weighted imaging for assessing the aggressiveness of prostate cancer: A histogram analysis].
    Yu YN; Zhang SJ
    Zhonghua Nan Ke Xue; 2019 Dec; 25(12):1106-1112. PubMed ID: 32251563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
    Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
    Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
    Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.